Background: Background Sulbactam irreversibly inhibits the hydrolytic activity of beta-lactamases. This compound is commercially available in combination with either ampicillin or cefoperazone. In each instance, the activity of the partner antibiotic against beta-lactamase producing bacteria is restored. In this context the present study was aimed to find out the antimicrobial susceptibility pattern of GNB against cefaperazone-sulbactam and to correlate its activity against commonly used antimicrobials for treatment of GNB.Methods: All Gram negative bacilli isolated from different clinical samples during a period of three months were tested against cefaperazone-sulbactam, meropenem, ceftazidime, cefotaxime, ceftriaxone, chloromphenicol, cotrimoxazole, ampicillin, amikacin, gentamycin, nalidixic acid, ciprofloxacin, ofloxacin, norfloxacin, nitrofuratoin, aztreonam, carbenicillin, piperacillin and tobramycin using standard Kirby-Bauer disc diffusion antimicrobial susceptibility testing method. The susceptibility was recorded as susceptible, intermediate susceptible and resistant by measuring the zone of inhibition they showed. The data were recorded in Microsoft excel sheet and analyzed in terms of percentage.Results: A total of 406 Gram negative bacilli were isolated from different clinical samples. Majority of samples were from females (59.4%). The mean age of patient's was 34.85. Out of 15 different species of GNB, Escherichia coli was the frequent isolate (56.4%), followed by Acinetobacter anitratus (17.5%), Klebsiella pneumoniae (9.1%) and Pseudomonas aeroginosa (5.9%). Almost all were isolated from urine (66.7%), pus (19.2%) and blood (7.9%). Ten percent of isolates were resistant to meropenem, which was the least resistant drug, followed by cefaperazone-sulbactam (14.7%) followed by amikacin (26.25%), chloromphenicol (38.46%). Isolates showed high degree of resistance against cephalosporins ranging from 73% to 96%.
Conclusion:Gram negative bacilli showed high level of susceptibility towards cefaperazone-sulbactam combination. It can be considered as a cheap alternative in treatment of severe infections caused by gram negative bacilli in our setting which would reduce the cost of other expensive antimicrobials agents.